Birth Defects Study To Evaluate Pregnancy exposureS (BD-STEPS) II

The summary for the Birth Defects Study To Evaluate Pregnancy exposureS (BD-STEPS) II grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention ERA, which is the U.S. government agency offering this grant.
Birth Defects Study To Evaluate Pregnancy exposureS (BD-STEPS) II: CDC has previously implemented population based case control studies of birth defects known as the National Birth Defects Prevention Study (NBDPS) for births from 1997-2011 and the Birth Defects Study To Evaluate Pregnancy exposureS (BD-STEPS I) which started with births in 2014 and is ongoing. The purpose of BD-STEPS II is to identify causes of birth defects and stillbirths using epidemiologic and genetic research methods and provide information that could be translated into public health prevention messages. The activities under this NOFO will be supported by two separate but related funding components: Component A. BD-STEPS II Core. To support the epidemiological and genetic research capability of the Centers for Birth Defects Research and Prevention (CBDRP) through BD-STEPS. The intent of this BD-STEPS II is to carry out BD-STEPS using the same basic study design currently used by grantees with a focus on the key areas of: (1) maternal chronic diseases and their treatments; (2) infectious disease in pregnancy; and (3) medications. In BD-STEPS II, we will add focus on infectious causes of birth defects, and pilots will be conducted to determine feasibility of medication use validation. Both new sites and current BD-STEPS sites are encouraged to apply for this component. Component B. BD-STEPS stillbirth. To support the exploration of modifiable risk factors for stillbirths. The intent of this component is to conduct a case-control study of stillbirth risk factors using the BD-STEPS II Core interview and a follow-up interview with mothers affected by stillbirths and mothers of livebirths. To be funded for Component B, applicants must have a responsive application for Component A and receive Component A funding. Both new sites and current BD-STEPS sites are encouraged to apply for this component.
Federal Grant Title: Birth Defects Study To Evaluate Pregnancy exposureS (BD-STEPS) II
Federal Agency Name: Centers for Disease Control and Prevention ERA (HHS-CDC-HHSCDCERA)
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-DD-18-001
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.073
CFDA Descriptions: Information not provided
Current Application Deadline: February 20th, 2018
Original Application Deadline: February 20th, 2018
Posted Date: December 21st, 2017
Creation Date: December 21st, 2017
Archive Date: March 22nd, 2018
Total Program Funding: $28,500,000
Maximum Federal Grant Award: $1,100,000
Minimum Federal Grant Award: $700,000
Expected Number of Awards: 6
Cost Sharing or Matching: No
Last Updated: December 21st, 2017
Applicants Eligible for this Grant
Unrestricted (i.e., open to any type of entity below), subject to any clarification in text field entitled "Additional Information on Eligibility"
Additional Information on Eligibility
For an application to be considered, it must be responsive to the following special eligibility requirements: Component A. BD-STEPS II CORE recipient: Access to a pre-existing population-based birth defects surveillance system that can provide data on all birth defects listed in Table 1 and access to necessary data sources to ascertain liveborn control infants (i.e. vital records or birth hospital records) as evidenced by a letter from the State health department or other State or private organization. Description of the selected birth population and geographic area which has to include 30,000 – 75,000 births annually as evidenced by a table listing the counties in the covered area, number of births in 2015, and race/ethnic distribution. Evidence of legal access to the birth defects surveillance system is required. If the applicant is not a State health department, inclusion of a letter or memorandum of understanding from the State health department confirming the applicant has access to the necessary data sources in order to ascertain case and control subjects. Access to the state’s National Electronic Disease Surveillance (NEDS) system for ascertainment of reportable infections as evidenced by a letter of support from the State's NEDS program. Component B. BD-STEPS Stillbirth recipient: Access to necessary data sources to ascertain stillborn infants (i.e. fetal death records or birth hospital records) as evidenced by a letter from the State health department or other State or private organization. Description of the selected birth population and geographic area that includes 30,000 – 75,000 births annually as evidenced by a table listing the counties in the covered area, number of births in 2015, and race/ethnic distribution. This area has to be the same geographical area as described for Component A.
Grant Announcement Contact
Marcela Law
mah7@cdc.gov

Grants Policy
Similar Government Grants
Reaching Healthcare Professionals in the Prevention of Fetal Alcohol Spectrum Disorders
Reaching Healthcare Professionals in the Prevention of Fetal Alcohol Spectrum Disorders th...
Promoting Resources for Fetal Alcohol Spectrum Disorders Awareness and Prevention
Implementing Alcohol Screening and Brief Intervention in Healthcare Systems Providing Wome...
Surveillance, intervention, and referral to services activities for infants with microceph...
Surveillance of Neural Tube Defects (NTDs) and Other Birth Defects in Low and Middle Incom...
Increase Awareness of Alveolar Capillary Dysplasia (ACD) Among Health Care Providers
Utilizing Existing Birth Defects Surveillance Programs to Include Surveillance Data on Sti...
More Grants from the Centers for Disease Control and Prevention ERA
The GAIN (Greater Access and Impact with NAT) Study: Improving HIV Diagnosis, Linkage to C...
Using Real-time Prescription and Insurance Claims Data to Support the HIV Care Continuum
Surveillance for Respiratory Syncytial Virus (RSV) and Other Viral Respiratory Infections ...
Increasing Influenza and Tdap Vaccination of Pregnant Women in Obstetric/Gynecologic Pract...
Understanding and Improving Immunization Services among Adult Hospital Inpatient and Obser...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2018 FederalGrants.com